Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 73.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 270,029 shares of the medical equipment provider’s stock after acquiring an additional 114,149 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Intuitive Surgical were worth $132,657,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Massachusetts Financial Services Co. MA acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $558,807,000. International Assets Investment Management LLC boosted its stake in Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after purchasing an additional 1,088,415 shares during the period. FMR LLC grew its position in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB increased its stake in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares during the period. Finally, State Street Corp raised its holdings in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ISRG. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Truist Financial boosted their target price on Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. Citigroup increased their price target on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Stock Performance

ISRG stock traded up $0.63 on Friday, reaching $544.65. The company had a trading volume of 647,608 shares, compared to its average volume of 1,154,680. The company’s fifty day moving average is $535.11 and its 200 day moving average is $493.61. The company has a market cap of $193.99 billion, a P/E ratio of 87.56, a PEG ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Activity

In other news, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This represents a 88.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 over the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.